81 related articles for article (PubMed ID: 18440882)
21. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial.
Kim S; Gaber MW; Zawaski JA; Zhang F; Richardson M; Zhang XA; Yang Y
Biomaterials; 2009 Sep; 30(27):4743-51. PubMed ID: 19501395
[TBL] [Abstract][Full Text] [Related]
22. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
[TBL] [Abstract][Full Text] [Related]
23. Biostability and biological performance of a PDMS-based polyurethane for controlled drug release.
Simmons A; Padsalgikar AD; Ferris LM; Poole-Warren LA
Biomaterials; 2008 Jul; 29(20):2987-95. PubMed ID: 18436300
[TBL] [Abstract][Full Text] [Related]
24. A poly(glycerol-sebacate-curcumin) polymer with potential use for brain gliomas.
Sun ZJ; Sun B; Tao RB; Xie X; Lu XL; Dong DL
J Biomed Mater Res A; 2013 Jan; 101(1):253-60. PubMed ID: 22941780
[TBL] [Abstract][Full Text] [Related]
25. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes.
Guo Q; Knight PT; Mather PT
J Control Release; 2009 Aug; 137(3):224-33. PubMed ID: 19376173
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of biocompatibility and mechanical behavior of chitin-based polyurethane elastomers. Part-II: Effect of diisocyanate structure.
Zia KM; Zuber M; Bhatti IA; Barikani M; Sheikh MA
Int J Biol Macromol; 2009 Jan; 44(1):23-8. PubMed ID: 19041889
[TBL] [Abstract][Full Text] [Related]
27. Anti-proliferative and pro-apoptotic effect of CPT13, a novel camptothecin analog, on human colon cancer HCT8 cell line.
Wang LM; Li QY; Zu YG; Fu YJ; Chen LY; Lv HY; Yao LP; Jiang SG
Chem Biol Interact; 2008 Nov; 176(2-3):165-72. PubMed ID: 18708040
[TBL] [Abstract][Full Text] [Related]
28. Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
Sahin A; Vercamer C; Kaminski A; Fuchs T; Florin A; Hahne JC; Mattot V; Pourtier-Manzanedo A; Pietsch T; Fafeur V; Wernert N
Int J Oncol; 2009 Feb; 34(2):377-89. PubMed ID: 19148472
[TBL] [Abstract][Full Text] [Related]
29. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
30. Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release.
Mandal B; Halder KK; Dey SK; Bhoumik M; Debnath MC; Ghosh LK
Pharmazie; 2009 Jul; 64(7):445-9. PubMed ID: 19694181
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
33. In vitro fibroblast response to polyurethane organosilicate nanocomposites.
Styan KE; Martin DJ; Poole-Warren LA
J Biomed Mater Res A; 2008 Sep; 86(3):571-82. PubMed ID: 17994560
[TBL] [Abstract][Full Text] [Related]
34. Silk fibroin spheres as a platform for controlled drug delivery.
Wenk E; Wandrey AJ; Merkle HP; Meinel L
J Control Release; 2008 Nov; 132(1):26-34. PubMed ID: 18761384
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitumor activity of novel 20s-camptothecin analogues.
Li Q; Lv H; Zu Y; Qu Z; Yao L; Su L; Liu C; Wang L
Bioorg Med Chem Lett; 2009 Jan; 19(2):513-5. PubMed ID: 19056266
[TBL] [Abstract][Full Text] [Related]
36. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
37. Development and characterisation of novel cross-linked bio-elastomeric materials.
Srokowski EM; Woodhouse KA
J Biomater Sci Polym Ed; 2008; 19(6):785-99. PubMed ID: 18534097
[TBL] [Abstract][Full Text] [Related]
38. Biocompatible epoxy modified bio-based polyurethane nanocomposites: mechanical property, cytotoxicity and biodegradation.
Dutta S; Karak N; Saikia JP; Konwar BK
Bioresour Technol; 2009 Dec; 100(24):6391-7. PubMed ID: 19683433
[TBL] [Abstract][Full Text] [Related]
39. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
[TBL] [Abstract][Full Text] [Related]
40. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
